| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Janku Filip is a Chief Medical Officer at GLUE. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $1.5M at current prices.
Janku Filip's largest disclosed position is in GLUE as Chief Medical Officer, worth about $1.5M. The recent filings there lean toward selling, a net 65,596 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 5,407 | $24.50 | $132,471.50 | -8.2% | -51.6% | - | |
| Jun 29, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 6,000 | $22.95 | $137,700.00 | -9.1% | -51.0% | - | |
| Jun 24, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 41,845 | $21.08 | $882,203.48 | -41.1% | -39.6% | - | |
| Feb 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Sell | 9,189 | $19.50 | $179,160.69 | -12.2% | -1.6% | - | |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.0% | +17.6% | - |